Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy
ER Kyvsgaard, ACH Riley, MR Clausen, M Harsløf… - Blood, 2023 - Elsevier
Introduction: Patients with hematological malignancies are at an increased risk of morbidity
and mortality after COVID-19 infection. Especially patients treated with chimeric antigen …
and mortality after COVID-19 infection. Especially patients treated with chimeric antigen …